Chemokine Therapeutics Corp.
2386 East Mall (UBC), Suite 208
Vancouver
British Columbia
V6T1Z3
Canada
Tel: 604-822-0301
Fax: 604-822-0302
Website: http://www.chemokine.net/
83 articles about Chemokine Therapeutics Corp.
-
Chemokine Therapeutics Corp. Announces Intention to File a Proposal to Creditors
12/8/2008
-
Chemokine Therapeutics Corp. Announces Third Quarter 2008 Financial and Operating Results
11/10/2008
-
Chemokine Therapeutics Corp. Announces Three Posters Presented on Its Lead Compound, CTCE-9908, at the 2008 EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Conference
10/28/2008
-
Chemokine Therapeutics Corp. Engages Investment Banker
10/22/2008
-
Chemokine Therapeutics Corp. Launches Strategic Financial Initiative
9/24/2008
-
Dr. Andrew Zhu Joins Chemokine Therapeutics Corp.' Clinical Advisory Board
8/12/2008
-
Chemokine Therapeutics Corp. Announces Second Quarter 2007 Financial and Operating Results
8/11/2008
-
Chemokine Therapeutics Corp. Announces Breast Cancer Data Presented at a Metastasis Conference With Lead Compound, CTCE-9908
8/6/2008
-
Chemokine Therapeutics Corp. Announces Board Changes
7/21/2008
-
Chemokine Therapeutics Corp. Announces Issuance of U.S. Patent
7/2/2008
-
Chemokine Therapeutics Corp. Closes $885,000 Offering
6/16/2008
-
Chemokine Therapeutics Corp. Announces Final Results of CTCE-9908 Phase I/II Clinical Trial in Late Stage Cancer Patients
6/12/2008
-
Chemokine Therapeutics Corp. Announces Issuance of Two New U.S. Patents
5/28/2008
-
Chemokine Therapeutics Corp. Announces First Quarter 2008 Financial and Operating Results
5/15/2008
-
Chemokine Therapeutics Corp. Announces Liver Cancer Data Presented at the American Association for Cancer Research Meeting on Its Lead Compound, CTCE-9908
4/30/2008
-
Chemokine Therapeutics Corp. Announces Positive Data Presented at the American Association for Cancer Research Annual Meeting on Lead Product Candidate CTCE-9908
4/23/2008
-
Chemokine Therapeutics Corp. Announces New President And Chief Executive Officer
4/16/2008
-
Chemokine Therapeutics Corp. Announces 2007 Financial and Operating Results
4/7/2008
-
Dr. Anthony Tolcher to Speak at the American Association for Cancer Research Annual Meeting on Chemokine Therapeutics Corp.'s Lead Drug Candidate CTCE-9908
3/25/2008
-
Chemokine Therapeutics Corp. Receives Approval From Health Canada to Commence Phase II Study in Liver Cancer
3/5/2008